Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach Noel10 passages
• Center, Seattle, Washington4 Ansun BioPharma, San Diego, CaliforniaCorresponding Author:16 passages
• Centre, University of Tampere Medical School, Finland2 Department of Preventive Medicine, Poznan University of Medical Sciences, Poland3 Vaccine Research,29 passages
• Defining Pediatric Diarrhea in Low-Resource Settings Levine18 passages
• Definitions for Drug-Resistant Tuberculosis in Children Seddon36 passages
• Determinants and Impact of Giardia Infection in the First 2 Years of Life in the MAL-ED Birth Cohort Rogawski31 passages
• Division, Fred Hutchinson Cancer Research Center, Seattle, WashingtonCorrespondence: A. Waghmare, MD, Pediatric Infectious Diseases Division, Seattle Children’s Hospital, 4800 Sand Point25 passages
• Editor's ChoiceTime to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a34 passages
• J Pediatric Infect Dis Soc1127 passages
• Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia Stockmann Chris 1Ampofo Krow 1Killpack Jarrett 1Williams34 passages
• Rule-Out Outbreak: 24-Hour Metagenomic Next-Generation Sequencing for Characterizing Respiratory Virus Source for Infection Prevention Greninger15 passages
• The Burden of Infant Meningococcal Disease in the United States23 passages
• Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam4 Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UKCorresponding Author:14 passages
• Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for Vaccination Gebremeskel10 passages